• Tue, June 6, 2023
Sarah James Maintained (AMED) at Hold with Increased Target to $100 on, Jun 6th, 2023
Sarah James of Cantor Fitzgerald, Maintained "Amedisys, Inc." (AMED) at Hold with Increased Target from $91 to $100 on, Jun 6th, 2023.
Sarah has made no other calls on AMED in the last 4 months.
There are 6 other peers that have a rating on AMED. Out of the 6 peers that are also analyzing AMED, 3 agree with Sarah's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Gary Taylor of "TD Cowen" Maintained at Hold with Decreased Target to $84 on, Monday, May 8th, 2023
- Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $88 on, Friday, May 5th, 2023
- Scott Fidel of "Stephens & Co." Reiterated at Hold and Held Target at $103 on, Thursday, May 4th, 2023
These are the ratings of the 3 analyists that currently disagree with Sarah
- David Macdonald of "Truist Securities" Maintained at Strong Buy with Decreased Target to $97 on, Thursday, May 4th, 2023
- Ben Hendrix of "RBC Capital" Maintained at Buy with Decreased Target to $111 on, Tuesday, February 21st, 2023
- Mark Miller of "Benchmark" Maintained at Strong Buy with Decreased Target to $115 on, Thursday, February 16th, 2023